BACKGROUND: Parathyroidectomy for primary hyperparathyroidism (PHPT) is followed by a decrease in the severity of symptoms reported on the Pasieka's parathyroid symptoms score (PPSS) and SF-36 questionnaires. Some argue that such benefits are short-lived. This study investigates the severity of symptoms at more than 12 months after parathyroidectomy. METHODS: A prospective database collected clinical/operative data on consecutive patients with PHPT. PPSS was calculated as the sum of the 13 parameters self-assessed using a visual analog scale. SF-36(v2) was analyzed using commercially available software (QualityMetric Inc., Lincoln, USA). RESULTS: Over 3-year interval, 166 patients (119 F/47 M, age 15-89 years) were operated for with PHPT (Ca 2.90 ± 0.25 mmol/L, PTH 21.64 ± 23.05 pmol/L). Their preoperative PPSS ranged 0-1,260 (median 413) and did not correlate with the severity of hypercalcemia. One hundred and seven patients responded when contacted by post at 18 ± 6 months postoperatively. Their postoperative PPSS was significantly lower (398 ± 226 to 231 ± 203, p < 0.001) and in 55 of 107 patients the severity of symptoms reduced by at least 50%. Most significant improvements were for mood (36 ± 33 vs. 16 ± 23), weakness/tiredness (37 ± 32 vs. 17 ± 23), irritability (35 ± 31 vs. 17 ± 21), and thirst (37 ± 32 vs. 18 ± 25; p < 0.0001). Physical and mental component scores of SF-36 questionnaire improved in patients whose PPSS decreased postoperatively. CONCLUSION: Symptomatic benefits persist for at least 1 year after parathyroidectomy in the majority of patients with PHPT.
BACKGROUND: Parathyroidectomy for primary hyperparathyroidism (PHPT) is followed by a decrease in the severity of symptoms reported on the Pasieka's parathyroid symptoms score (PPSS) and SF-36 questionnaires. Some argue that such benefits are short-lived. This study investigates the severity of symptoms at more than 12 months after parathyroidectomy. METHODS: A prospective database collected clinical/operative data on consecutive patients with PHPT. PPSS was calculated as the sum of the 13 parameters self-assessed using a visual analog scale. SF-36(v2) was analyzed using commercially available software (QualityMetric Inc., Lincoln, USA). RESULTS: Over 3-year interval, 166 patients (119 F/47 M, age 15-89 years) were operated for with PHPT (Ca 2.90 ± 0.25 mmol/L, PTH 21.64 ± 23.05 pmol/L). Their preoperative PPSS ranged 0-1,260 (median 413) and did not correlate with the severity of hypercalcemia. One hundred and seven patients responded when contacted by post at 18 ± 6 months postoperatively. Their postoperative PPSS was significantly lower (398 ± 226 to 231 ± 203, p < 0.001) and in 55 of 107 patients the severity of symptoms reduced by at least 50%. Most significant improvements were for mood (36 ± 33 vs. 16 ± 23), weakness/tiredness (37 ± 32 vs. 17 ± 23), irritability (35 ± 31 vs. 17 ± 21), and thirst (37 ± 32 vs. 18 ± 25; p < 0.0001). Physical and mental component scores of SF-36 questionnaire improved in patients whose PPSS decreased postoperatively. CONCLUSION: Symptomatic benefits persist for at least 1 year after parathyroidectomy in the majority of patients with PHPT.
Authors: G B Talpos; H G Bone; M Kleerekoper; E R Phillips; M Alam; M Honasoge; G W Divine; D S Rao Journal: Surgery Date: 2000-12 Impact factor: 3.982
Authors: Janice L Pasieka; Louise L Parsons; Michael J Demeure; Stuart Wilson; Peter Malycha; Jean Jones; Beth Krzywda Journal: World J Surg Date: 2002-05-21 Impact factor: 3.352
Authors: Monica S Eigelberger; W Keat Cheah; Philip H G Ituarte; Leanne Streja; Quan-Yang Duh; Orlo H Clark Journal: Ann Surg Date: 2004-04 Impact factor: 12.969
Authors: Dominika Babińska; Marcin Barczyński; Tomasz Stefaniak; Tomasz Osęka; Anna Babińska; Dariusz Babiński; Krzysztof Sworczak; Andrzej J Lachiński; Wojciech Nowak; Zbigniew Sledziński Journal: Langenbecks Arch Surg Date: 2011-12-08 Impact factor: 3.445
Authors: Priya R Pathak; Sara E Holden; Sarah C Schaefer; Glen Leverson; Herbert Chen; Rebecca S Sippel Journal: J Surg Res Date: 2014-03-02 Impact factor: 2.192
Authors: Sara E Murray; Priya R Pathak; David S Pontes; David F Schneider; Sarah C Schaefer; Herbert Chen; Rebecca S Sippel Journal: Surgery Date: 2013-10-04 Impact factor: 3.982
Authors: Eeva M Ryhänen; Ilkka Heiskanen; Harri Sintonen; Matti J Välimäki; Risto P Roine; Camilla Schalin-Jäntti Journal: Endocr Connect Date: 2015-07-08 Impact factor: 3.335
Authors: Susan M Webb; Manel Puig-Domingo; Carles Villabona; Manuel Muñoz-Torres; Jordi Farrerons; Xavier Badia Journal: Health Qual Life Outcomes Date: 2013-06-18 Impact factor: 3.186